SEC Tracker
Get the app

Possible new Yarrow Bioscience shares

YARWDilution

Last raise Sep 11, 2026, 424B5: 5.8M shares (216.1% of the 2.7M then) at $26.00, $150M gross

Known so far: 5.8M possible new shares (216.1% of today's 2.7M) · shelf room about $0 at the $32.0M float · not yet read: warrants, converts, options, ATM.

Shelf room

  • Room today about $0, maybe lower
  • One third of float $10.7M ($32.0M float, Jun 30, 2025)
  • Room grows Sep 11, 2027
How this is worked out

Shelf room about $0 on the S-3 of Mar 1, 2024: the baby-shelf rule (public float under $75M) caps sales at one third of the $32.0M public float stated as of Jun 30, 2025, $10.7M, less $150M sold off it in the last 12 months (424B5 Sep 11, 2026 $150M); 1 more sale off the shelf with no size read, so the room may be lower; more was sold than one third of this float, so the float the rule measured at that sale was higher, and the room for a new sale depends on the float within 60 days before it; it grows again from Sep 11, 2027, 12 months after the first sale counted. Sources: S-3 Mar 1, 2024, effective Mar 14, 2024 · public float, as of Jun 30, 2025 · 424B5 Sep 11, 2026 · 424B5 Sep 11, 2026.

What could become new Yarrow Bioscience (YARW) shares, from the S-3 and 424B prospectus covers we have read.

Read so far: the cover share count (2.7M shares, +424% from 509K on Aug 7, 2025, adjusted for the 1-for-50 reverse split by Aug 10, 2026) and the prospectus covers below. Not read yet: warrants, convertible notes, options and RSUs and an ATM program. Read them on EDGAR: the latest 10-Q · S-3 shelf filings.

Shares outstanding

2.7M

Nov 2024 to Aug 2026: from 295K to 2.7M. Adjusted for the 1-for-50 reverse split by Aug 10, 2026: each earlier count is divided by the ratio of every split after it.

From the share count on the cover of each 10-Q and 10-K, dated as each cover states.